Quality of Life Issues in Patients with Skull Base Tumours

  • Avraham Abergel
  • Dan M. Fliss
  • Ziv Gil
Part of the Head and Neck Cancer Clinics book series (HNCC)


A fundamental goal of medical care is the maintenance or improvement of quality of life (QOL) for all those who need and seek care. In general, QOL can be defined as a multidimensional construct that includes performance and enjoyment of social roles, physical health, intellectual functioning, emotional state and life satisfaction or well-being [1]. QOL is assessed in an effort to improve treatment modalities, to promote restoration of the patient’s daily functions, and to accelerate his or her return to normal life. By estimating the influence of surgical procedures on QOL, the most appropriate surgical approach can be selected for a given patient. A thorough understanding of the different aspects of QOL can help surgeons improve assessment and management of patients, identify specific impediments as early as possible during follow up, and direct specific medical interventions to patients with increased risk and poor outcome [2].


Skull Base Vestibular Schwannomas Skull Base Surgery Skull Base Tumour Glasgow Benefit Inventory 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Pearlman RA, Uhlmann RF. Quality of life in the elderly. J Appl Gerontol 1988;7:316–30.Google Scholar
  2. 2.
    Fitzpatrick R, Fletcher A, Gore S, et al. Quality of life measures in health care. I: Applications and issues in assessment. BMJ 1992;305:1074–77.PubMedCentralCrossRefPubMedGoogle Scholar
  3. 3.
    Patel SG, Singh B, Polluri A, et al. Craniofacial surgery for malignant skull base tumors: Report of an international collaborative study. Cancer 2003;98:1179–87.CrossRefPubMedGoogle Scholar
  4. 4.
    Gil Z, Patel SG, Singh B, et al. International Collaborative Study Group Analysis of prognostic factors in 146 patients with anterior skull base sarcoma: An international collaborative study. Cancer 2007;110:1033–41.CrossRefPubMedGoogle Scholar
  5. 5.
    Gil Z, Abergel A, Spektor S, et al. Development of a cancer-specific anterior skull base quality of life questionnaire. J Neurosurg 2004;100:813–19.CrossRefPubMedGoogle Scholar
  6. 6.
    Meyers CA, Geara F, Wong P, et al. Neurocognitive effects of therapeutic irradiation for base of skull tumors. Int J Radiation Biol Phys 2000;46:51–5.CrossRefGoogle Scholar
  7. 7.
    Meyers CA, Hess KR. Multifaceted end points in brain tumor clinical trials: Cognitive deterioration precedes MRI progression. Neuro-Oncol 2003;5:89–95.PubMedCentralPubMedGoogle Scholar
  8. 8.
    Weymuller EA, Yueh B, Deleyiannis FW, et al. Quality of life in patients with head and neck cancer: Lessons learned from 549 prospectively evaluated patients. Arch Otolaryngol Head Neck Surg 2000;126:329–35.CrossRefPubMedGoogle Scholar
  9. 9.
    Tang ST, McCorkle R. Use of proxies in quality of life research for cancer patients at the end of life: A literature review. Cancer Invest 2002;20:1086–104.CrossRefPubMedGoogle Scholar
  10. 10.
    Sneeuw KC, Aaronson NK, Osoba D, et al. The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care 1997;35:490–506.CrossRefPubMedGoogle Scholar
  11. 11.
    Gil Z, Abergel A, Spektor S, et al. Patient, caregiver and surgeon perceptions of quality of life following anterior skull base surgery. Arch Otolaryngol Head Neck Surg 2004;130:1276–81.CrossRefPubMedGoogle Scholar
  12. 12.
    Portenoy RK. Quality of life issues in patients with head and neck cancer. In: Harrison LB (ed). Head and neck cancer. New York: Plenum Press, 1995:218–31.Google Scholar
  13. 13.
    Ware JE, Sherbourne C. The MOS 36-item short-form health survey (SF-36). Med Care 1992;30:473–83.CrossRefPubMedGoogle Scholar
  14. 14.
    Neil-Dwyer G, Lang DA, Davis A. Outcome from complex neurosurgery: An evidence based approach. Acta Neurochir 2000;142:367–71.CrossRefPubMedGoogle Scholar
  15. 15.
    Baumann I, Polligkeit J, Blumenstock G, et al. Quality of life after unilateral acoustic neuroma surgery via middle cranial fossa approach. Acta Oto-Laryngol 2005;125:585–91.CrossRefGoogle Scholar
  16. 16.
    da Cruz MJ, Moffat DA, Hardy DG. Postoperative quality of life in vestibular schwannoma patients measured by the SF-36 health questionnaire. Laryngoscope 2000;110:151–55.CrossRefPubMedGoogle Scholar
  17. 17.
    Gliklich RE, Goldsmith TA, Funk GF. Are head and neck specific quality of life measures necessary? Head Neck 1997;19:474–80.CrossRefPubMedGoogle Scholar
  18. 18.
    Gil Z, Abergel A, Spektor S, et al. Quality of life following surgery for anterior skull base tumors. Arch Otolaryngol Head Neck Surg 2003;129:1303–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Abergel A, Fliss DM, Margalit N, et al. A prospective evaluation of short-term health-related quality of life in patients undergoing anterior skull base surgery. Skull Base 2010;20:27–33.PubMedCentralCrossRefPubMedGoogle Scholar
  20. 20.
    Woertgen C, Rothoerl RD, Hosemann W, et al. Quality of life following surgery for malignancies of the anterior skull base. Skull Base 2007;17:119–23.PubMedCentralCrossRefPubMedGoogle Scholar
  21. 21.
    Mohsenipour I, Deusch E, Gabl M, et al. Quality of life in patients after meningioma resection. Acta Neurochir (Wien) 2001;143:547–53.CrossRefGoogle Scholar
  22. 22.
    Lang DA, Neil-Dwyer G, Garfield J. Outcome after complex neurosurgery: The caregiver’s burden is forgotten. J Neurosurg 1999;91:359–63.CrossRefPubMedGoogle Scholar
  23. 23.
    Nikolopoulos TP, Johnson I, O’Donoghue GM. Quality of life after acoustic neuroma surgery. Laryngoscope 1998;108:1382–5.CrossRefPubMedGoogle Scholar
  24. 24.
    Tufarelli D, Meli A, Alesii A, et al. Quality of life after acoustic neuroma surgery. Otol Neurotol 2006;27:403–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Baumann I, Polligkeit J, Blumenstock G, et al. Quality of life after unilateral acoustic neuroma surgery via middle cranial fossa approach. Acta Otolaryngol 2005;125: 585–91.CrossRefPubMedGoogle Scholar
  26. 26.
    Kelleher MO, Fernandes MF, Sim DW, et al. Health-related quality of life in patients with skull base tumours. Br J Neurosurg 2002;16:16–20.CrossRefPubMedGoogle Scholar
  27. 27.
    Myrseth E, Moller P, Pedersen PH, et al. Vestibular schwannomas: Clinical results and quality of life after microsurgery or gamma knife radiosurgery. Neurosurgery 2005;56:927–35; Discussion 927–35.PubMedGoogle Scholar
  28. 28.
    Sandooram D, Grunfeld EA, McKinney C, et al. Quality of life following microsurgery, radiosurgery and conservative management for unilateral vestibular schwannoma. Clin Otolaryngol Allied Sci 2004;29:621–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Page RC, Hammersley MS, Burke CW, et al. An account of the quality of life of patients after treatment for non-functioning pituitary tumours. Clin Endocrinol (Oxf) 1997;46:401–6.CrossRefGoogle Scholar
  30. 30.
    Karavitaki N, Brufani C, Warner JT, et al. Craniopharyngiomas in children and adults: Systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 2005;62:397–409.CrossRefGoogle Scholar
  31. 31.
    Kendall-Taylor P, Jonsson PJ, Abs R, et al. The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. Eur J Endocrinol 2005;152:557–67.CrossRefPubMedGoogle Scholar
  32. 32.
    Heald AH, Ghosh S, Bray S, et al. Long-term negative impact on quality of life in patients with successfully treated Cushing’s disease. Clin Endocrinol (Oxf) 2004;61:458–65.CrossRefGoogle Scholar
  33. 33.
    Peace KA, Orme SM, Thompson AR, et al. Cognitive dysfunction in patients treated for pituitary tumours. J Clin Exp Neuropsychol 1997;19:1–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Noad R, Narayanan KR, Howlett T, et al. Evaluation of the effect of radiotherapy for pituitary tumours on cognitive function and quality of life. Clin Oncol (R Coll Radiol) 2004;16:233–7.CrossRefGoogle Scholar
  35. 35.
    Van Beek AP, van den Bergh AC, van den Berg LM, et al. Radiotherapy is not associated with reduced quality of life and cognitive function in patients treated for non-functioning pituitary adenoma. Int J Radiat Oncol Biol Phys 2007;68:986–91.CrossRefPubMedGoogle Scholar
  36. 36.
    Dekkers OM, Biermasz NR, Smit JW, et al. Quality of life in treated adult craniopharyngioma patients. Eur J Endocrinol 2006;154:483–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Pereira AM, Schmid EM, Schutte PJ, et al. High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin Endocrinol (Oxf) 2005;62:197–204.CrossRefGoogle Scholar
  38. 38.
    Poretti A, Grotzer MA, Ribi K, et al. Outcome of craniopharyngioma in children: Long-term complications and quality of life. Dev Med Child Neurol 2004;46:220–9.CrossRefPubMedGoogle Scholar
  39. 39.
    Pant H, Bhatki AM, Snyderman CH, et al. Quality of life following endonasal skull base surgery. Skull Base 2010; 20: 35–40. PubMedCentralCrossRefPubMedGoogle Scholar
  40. 40.
    Bardiau FM, Taviaux NF, Albert A, et al. An intervention study to enhance postoperative pain management. Anesth Analg 2003;96:179–85.PubMedGoogle Scholar
  41. 41.
    Gil Z, Smith DB, Marouani, et al. Treatment of pain after head and neck surgeries: Control of acute pain after head and neck oncological surgeries. Otolaryngol Head Neck Surg 2006;135:182–8.Google Scholar
  42. 42.
    Gil Z, Cohen JT, Spektor S, et al. Anterior skull base surgery without prophylactic airway diversion procedures. Otolaryngol Head Neck Surg 2003;128:681–5.CrossRefPubMedGoogle Scholar
  43. 43.
    Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004;32:57–71.CrossRefPubMedGoogle Scholar
  44. 44.
    Razavi D, Allilaire JF, Smith M, et al. The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatr Scand 1996;94:205–10.CrossRefPubMedGoogle Scholar
  45. 45.
    Fisch MJ, Loehrer PJ, Kristeller J, et al. Hoosier Oncology Group. Fluoxetine versus placebo in advanced cancer outpatients: A double-blinded trial of the Hoosier Oncology Group. J Clin Oncol 2003;21:1937–43.CrossRefPubMedGoogle Scholar
  46. 46.
    Williams S, Dale J. The effectiveness of treatment for depression/depressive symptoms in adults with cancer: A systematic review. Br J Cancer 2006;94:372–90.PubMedCentralCrossRefPubMedGoogle Scholar
  47. 47.
    Barsevick AM, Sweeney C, Haney E, et al. A systematic qualitative analysis of psychoeducational interventions for depression in patients with cancer. Oncol Nurs Forum 2002;29:73–84.CrossRefPubMedGoogle Scholar
  48. 48.
    Spiegel D, Bloom JR, Kraemer HC, et al. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989;2:888–91.CrossRefPubMedGoogle Scholar
  49. 49.
    Fawzy FI, Fawzy NW, Hyun CS, et al. Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 1993;50:681–9.CrossRefPubMedGoogle Scholar
  50. 50.
    Richardson JL, Shelton DR, Krailo M, et al. The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol 1990;8:356–64.PubMedGoogle Scholar
  51. 51.
    Bordeleau L, Szalai JP, Ennis M, et al. Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: Overall effects of the intervention and an exploration of missing data. J Clin Oncol 2003;21:1944–51.CrossRefPubMedGoogle Scholar
  52. 52.
    Winzelberg AJ, Classen C, Alpers GW, et al. Evaluation of an internet support group for women with primary breast cancer. Cancer 2003;97:1164–73.CrossRefPubMedGoogle Scholar

Copyright information

© The Author(s) 2012

Authors and Affiliations

  1. 1.Department of Otolaryngology, Head and Neck and Maxillofacial SurgeryTel Aviv Sourasky Medical Center, Tel Aviv UniversityTel AvivIsrael
  2. 2.Head and Neck Surgery Unit, Department of Otolaryngology, Head and Neck and Maxillofacial SurgeryTel Aviv Sourasky Medical Center, Tel Aviv UniversityTel AvivIsrael

Personalised recommendations